Global child health priorities: What role for paediatric oncologists?

European Journal of Cancer

Volumn 44, Issue 16, 2008, Pages 2388-2396

  Kellie, Stewart J ^a,b   Howard, Scott C ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiology; Low income countries; Oncology; Paediatric; Public health; Twinning programmes

Indexed keywords

ALLOPURINOL; ANTIMETABOLITE; ASPARAGINASE; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINATE CALCIUM; MERCAPTOPURINE; METHOTREXATE; PROCARBAZINE; RETINOL; VINBLASTINE; VINCRISTINE;

ACCIDENT; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER SURVIVAL; CHILD HEALTH; CHILDHOOD CANCER; CONGENITAL MALFORMATION; DIARRHEA; ETHICS; HEALTH CARE PERSONNEL; HUMAN; HUMAN RIGHTS; INFECTION; ISCHEMIA; MALARIA; MEDICAL EDUCATION; MORBIDITY; NEUROLOGIC DISEASE; PNEUMONIA; POVERTY; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CANCER CARE FACILITIES; CAUSE OF DEATH; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HEALTH PERSONNEL; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; INTERNATIONAL COOPERATION; MALE; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; PROFESSIONAL PRACTICE; REGISTRIES; WORLD HEALTH;

EID: 54249118537     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.07.022     Document Type: Article

References (96)

1. Hargrave D.R., Hann I.I., Richards S.M., et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Brit J Haematol 112 2 (2001) 293-299
2. Eden O.B., Harrison G., Richards S., et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party. Leukemia 14 12 (2000) 2307-2320
3. McGregor L.M., Metzger M.L., Sanders R., et al. Pediatric cancers in the new millennium: dramatic progress, new challenges [see comment]. Oncology (Williston Park) 21 7 (2007) 809-820 [Discussion 820]
4. Rubnitz J.E., Lensing S., Zhou Y., et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 101 7 (2004) 1677-1684
5. UNICEF. Child survival. In: The state of the world's children 2008. Executive summary New York: United Nations Children's Fund (UNICEF); 2007. p. 1-42.
6. Lawn J.E., Cousens S., Zupan J., and Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? where? why?[see comment]. Lancet 365 9462 (2005) 891-900
7. Ahmad O.B., Lopez A.D., and Inoue M. The decline in child mortality: a reappraisal. Bull World Health Org 78 10 (2000) 1175-1191
8. Black R.E., Morris S.S., Bryce J., Black R.E., Morris S.S., and Bryce J. Where and why are 10 million children dying every year? [see comment]. Lancet 361 9376 (2003) 2226-2234
9. Bryce J., Boschi-Pinto C., Shibuya K., et al. WHO estimates of the causes of death in children [see comment]. Lancet 365 9465 (2005) 1147-1152
10. Black R.E., Allen L.H., Bhutta Z.A., et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371 9608 (2008) 243-260
11. The World's Forgotten Children. Lancet 2003;361(9351):1.
12. Bryce J., el Arifeen S., Pariyo G., et al. Reducing child mortality: can public health deliver?. Lancet 362 9378 (2003) 159-164
13. Mosley W., and Chen L.C. An analytical framework for the study of child survival in developing countries. Popul Develop Rev 10 suppl (1984) 24-45
14. Claeson M., and Waldman R.J. The evolution of child health programmes in developing countries: from targeting diseases to targeting people. Bull World Health Org 78 10 (2000) 1234
15. Victora C.G., Bryce J., Fontaine O., and Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Org 78 10 (2000) 1246
16. de Onis M., Frongillo E.A., and Blossner M. Is malnutrition declining? An analysis of changes in levels of child malnutrition since 1980. Bull World Health Org 78 10 (2000) 1222
17. Rutstein S.O. Factors associated with trends in infant and child mortality in developing countries during the 1990s. Bull World Health Org 78 10 (2000) 1256
18. Sachs J.D., and McArthur J.W. The Millennium Project: a plan for meeting the millennium development goals. Lancet 365 9456 (2005) 347-353
19. Sachs J.D. Health in the developing world: achieving the Millennium Development Goals. Bull World Health Org 82 12 (2004) 947-949
20. Cahill K, et al. High level forum on the health millennium development goals: selected papers, 2003-2005. Geneva: World Health Organization, 2006.
21. Bhutta Z.A. Why has so little changed in maternal and child health in south Asia. BMJ 321 (2000) 809-812
22. Engaging with global health. BMJ 2000;321:54-55.
23. Mortality statistics. Childhood, infant and perinatal. Series DH3 no. 32. In: National Statistics: The Stationery Office, London; 1999.
24. Bleyer W.A. The impact of childhood cancer on the United States and the world. CA: Cancer J Clin 40 6 (1990) 355-367
25. Gajalakshmi C.K., Shanta V., and Rama R. Registration of cancer mortality data in a developing area: Chennai (Madras, India) experience. Cancer Causes Contr 9 2 (1998) 131-136
26. Howard S.C., Metzger M.L., Wilimas J.A., et al. Childhood cancer epidemiology in low-income countries. Cancer 112 3 (2008) 461-472
27. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA: A Cancer J Clin 55 2 (2005) 74-108
28. Parkin D.M., Stiller C.A., Draper G.J., and Bieber C.A. The international incidence of childhood cancer. Int J Cancer 42 4 (1988) 511-520
29. Cole C. Registering childhood cancers. Lancet 364 (2004) 2074-2075
30. Shibuya K., Mathers C.D., Boschi-Pinto C., et al. Global and regional estimates of cancer mortality and incidence by site: II Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
31. Cancer Statistics Review, 1973-1986. Bethesda MD, Division of Cancer Prevention and Control Surveillance program. NIH Publication No. 89-2789. Bethesda, MD, National Cancer Institute, May 1989.
32. Steliarova-Foucher E., Stiller C., Kaatsch P., et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 364 9451 (2004) 2097-2105
33. Greaves M.F. An immunological window on leukaemia. Immunol Suppl 2 56-63 (1989) 64-65
34. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 2 8624 (1988) 1323-1327
35. UICC 2005. World cancer campaign: the time to act is now. Geneva: International Union against Cancer (UICC); 2005.
36. Metzger M.L., Howard S.C., Fu L.C., et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 362 9385 (2003) 706-708
37. Burton A. My child matters initiative awards: combating cancer in children in the developing world. Lancet Oncol 7 (2006) 13-14
38. UICC Global Cancer Control. Childhood cancer: rising to the challenge. Geneva: UICC; 2006.
39. World Health Organization. Essential medicines. .
40. Sikora K., Advani S., Koroltchouk V., et al. Essential drugs for cancer therapy: a World Health Organization consultation. Ann Oncol 10 4 (1999) 385-390
41. Anonymous. Essential drugs for cancer chemotherapy: memorandum from a WHO meeting. Bull World Health Org 1985;63(6):999-1002.
42. Anonymous. Essential drugs for cancer chemotherapy. WHO consultation. Bull World Health Org 1994;72(5):693-8.
43. Seuba X, Seuba X. A human rights approach to the WHO Model List of Essential Medicines. Bull World Health Org 2006;84(5):405-7 [Discussion 408-11].
44. World health Organization. Equitable access to essential medicines: a framework for collective action. In: WHO Policy Perspectives on Medicines. Geneva: WHO; 2004.
45. Pui C.H., Schrappe M., Masera G., et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 18 6 (2004) 1043-1053
46. 2004 World Bank Indicators. Washington: International Bank for Reconstruction and Development/The World Bank; 2004.
47. 't Hoen E. Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments. Bull World Health Org 84 5 (2006) 421-423
48. TRIPS and pharmaceutical patents: fact sheet. World Trade Organization, [accessed 29.03.2008].
49. The Doha declaration on the TRIPS agreement and public health. World Health Organization, [accessed 29.03.2008].
50. WTO decision on the implementation of paragraph 6 of the Doha declaration on the TRIPS agreement and public health. World Trade Organization, http://www.who.int/medicines/areas/policy/wto_impl_para6/en/print.html [accessed 29.03.2008].
51. World development report 2006: equity and development. The World Bank.http://www.wds.worldbank.org/external/default/WDSContentServer/IW3P/IB/2005/09/20/000112742_20050920110826/additional/841401968_2005082630000807.pdf.
52. Sala A., Barr R.D., Masera G., Consortium M., Sala A., Barr R.D., et al. A survey of resources and activities in the MISPHO family of institutions in Latin America: a comparison of two eras. Pediat Blood Cancer 43 7 (2004) 758-764
53. Reidenberg M. Are drugs for rare diseases 'essential'?. Bull World Health Org 84 (2006) 686
54. World Development Report. Focus 6 on regional inequality. The role of public policy in addressing spatial inequalities. 2005:204-205.
55. Ribeiro R.C., Marina N., and Crist W.M. St Jude Children's Research Hospital's International Outreach Program. Leukemia 10 3 (1996) 570-574
56. Dang-Tan T., Franco E.L., Dang-Tan T., and Franco E.L. Diagnosis delays in childhood cancer: a review. Cancer 110 4 (2007) 703-713
57. Simone J.V. Cancer care and clinical research for children in less developed countries: problems and promise. J Pediat Hematol/Oncol 22 6 (2000) 490-491
58. Pui C.H., Ribeiro R.C., Pui C.-.H., and Ribeiro R.C. International collaboration on childhood leukemia. Int J Hematol 78 5 (2003) 383-389
59. Eden T. Translation of cure for acute lymphoblastic leukaemia to all children. Brit J Haematol 118 4 (2002) 945-951
60. Ribeiro R.C., Pui C.H., Ribeiro R.C., and Pui C.-.H. Saving the children-improving childhood cancer treatment in developing countries. New Engl J Med 352 21 (2005) 2158-2160
61. Howard S.C., Ribeiro R.C., Pui C.H., Howard S.C., Ribeiro R.C., and Pui C.-.H. Strategies to improve outcomes of children with cancer in low-income countries. Eur J Cancer 41 11 (2005) 1584-1587
62. Magrath I., Shanta V., Advani S., et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 41 11 (2005) 1570-1583
63. Antillon F., Baez F.L., Barr R., et al. AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediat Blood Cancer 45 2 (2005) 107-110
64. Ekenze S.O., Agugua-Obianyo N.E.N., and Odetunde O.A. The challenge of nephroblastoma in a developing country. Ann Oncol 17 10 (2006) 1598-1600
65. Bonilla M., Moreno N., Marina N., et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador [see comment]. J Pediat Hematol/Oncol 22 6 (2000) 495-501
66. Veerman A.J.P., and Sumadiono S. Twinning: a rewarding scenario for development of oncology services in transitional countries. Pediat Blood Cancer 45 (2005) 103-106
67. Madani A., Zafad S., Harif M., et al. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco. Pediat Blood Cancer 46 4 (2006) 472-475
68. Masera G., Baez F., Biondi A., et al. North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua [see comment]. Lancet 352 9144 (1998) 1923-1926
69. Mostert S., Sitaresmi M.N., Gundy C.M., Sutaryo, Veerman A.J., Mostert S., et al. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 118 6 (2006) e1600-e1606
70. Quintana Y, Nambayan A, Ribeiro R, et al. Cure4Kids - building online learning and collaboration networks. In: AMIA 2003, Annual symposium proceedings/AMIA symposium. p. 978.
71. Workman G.M., Ribeiro R.C., Rai S.N., et al. Pediatric cancer knowledge: assessment of knowledge of warning signs and symptoms for pediatric cancer among Brazilian community health workers. J Cancer Edu 22 3 (2007) 181-185
72. Wilimas J.A., Donahue N., Chammas G., et al. Training subspecialty nurses in developing countries: methods, outcome, and cost. Med Pediat Oncol 41 2 (2003) 136-140
73. Leander C., Fu L.C., Pena A., et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediat Blood Cancer 49 6 (2007) 817-819
74. Donahue N., Wilimas J., Urbina C., et al. International hematology-oncology nursing education in Latin America. J Pediat Oncol Nurs 19 3 (2002) 79-83
75. Howard S.C., Campana D., Coustan-Smith E., et al. Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America. Leukemia 19 3 (2005) 323-325
76. Coustan-Smith E., Ribeiro R.C., Stow P., et al. A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood 108 1 (2006) 97-102
77. Chauvenet A.R., Martin P.L., Devidas M., et al. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood 110 4 (2007) 1105-1111
78. Ayoub L., Fu L., Pena A., et al. Implementation of a data management program in a pediatric cancer unit in a low income country. Pediat Blood Cancer 49 1 (2007) 23-27
79. Quintana Y, Howard S, Norland M, Patel A, O'Brien R, Ribeiro R, et al. Pond4Kids - an multi-site online Pediatric Oncology Research Database for collaborative protocol research. In: AMIA 2005, Annual symposium proceedings/AMIA symposium. p. 1090.
80. Sitthi-Amorn C., and Somrongthong R. Strengthening health research capacity in developing countries: a critical element for achieving health equity [see comment]. BMJ 321 7264 (2000) 813-817
81. Sitthi-Amorn C., Somrongthong R., and Janjaroen W.S. Economic and health care restructuring - the need for better governance. Int J Epidemiol 30 4 (2001) 717-719
82. Costello A., and Zumla A. Moving to research partnerships in developing countries. BMJ 321 (2000) 827-829
83. Caniza M.A., Clara W., Maron G., et al. Establishment of ethical oversight of human research in El Salvador: lessons learned. Lancet Oncol 7 12 (2006) 1027-1033
84. Chandy M. An approach to the management of leukemia in the developing world. Clin Lab Haematol 28 3 (2006) 147-153
85. Burkitt D. A sarcoma involving the jaws in African children. Brit J Surg 46 (1958) 218-223
86. Nkrumah F.K., and Perkins I.V. Burkitt's lymphoma: a clinical study of 110 patients. Cancer 37 2 (1976) 671-676
87. Banda L. Patterns of the most common malignancies in Malawi. In: Proceedings of the first continental meeting of the international society of pediatric oncology in Africa, Stellenbosch, South Africa: University of Stellenbosch Printers; 1995. p. 12-13.
88. van Hasselt E.J., and Broadhead R. Burkitt's lymphoma: a case file study of 160 patients treated in Queen Elizabeth Central Hospital from 1988 to 1992. Pediat Hematol Oncol 12 3 (1995) 277-281
89. Olweny C.L., Katongole-Mbidde E., Otim D., Lwanga S.K., Magrath I.T., and Ziegler J.L. Long-term experience with Burkitt's lymphoma in Uganda. Int J Cancer 26 3 (1980) 261-266
90. Kazembe P., Hesseling P.B., Griffin B.E., Lampert I., and Wessels G. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediat Oncol 40 1 (2003) 23-25
91. Hesseling P.B., Broadhead R., Molyneux E., et al. Malawi pilot study of Burkitt lymphoma treatment. Med Pediat Oncol 41 6 (2003) 532-540
92. Hesseling P., Broadhead R., Mansvelt E., et al. The 2000 Burkitt lymphoma trial in Malawi. Pediat Blood Cancer 44 3 (2005) 245-250
93. Banda L.T., Parkin D.M., Dzamalala C.P., and Liomba N.G. Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health 6 4 (2001) 296-304
94. Sinfield R.L., Molyneux E.M., Banda K., et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998-2003. Pediat Blood Cancer 48 5 (2007) 515-520
95. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., and Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Brit J Cancer 82 9 (2000) 1585-1592
96. Kruger C. Childhood cancer in developing countries. Lancet 365 (2005) 752-753